DownonthePharm said:
A few days old news, but anyone want to discuss? How do you think this will this effect the future of the pharmaceutical industry?
😱
http://money.cnn.com/2005/08/19/news/fortune500/vioxx/index.htm?cnn=yes
Well, I think this case will hurt Merck obviously, but it will also scare the hell out of these companies and hopefully increase post-approval oversight. I hope the FDA can trulyfind a way to improve their own processes and regulate these newer medications more effectively (also, to be sure and be more discriminating when choosing meds for fast track approval).
Overall, this is merely another warning sign to these pharma companies that the American public is after you, doesn't trust you, and that these types of problems are a disservice to science and the people who have worked hard to improve health outcomes (symptoms seen in an anti-science political/religious climate).
Now I don't agree with the perceptions of the American public or the above statements wholeheartedly. In my opinion, it seems the FDA cannot take every drug off the market bc of a very minute population of patients who have these adverse effects or deaths. These companies are not the definition of villany, and have increased our life span and improved countless people's lives However, cost and these types of events only bolster anti-pharma sentiments. More so, the media is just propelling ludicrous arguments, the public needs to understand the concept of risk, and companies need to start publishing journal articles that are held to the same critique as academic research. This will hopefully discontinue current practices by pharma that are hurting the credibility of American academic research.
Things must change, either a new functioning body specific to post-approval patient safety or increase the FDA's budget so they can abide by their mission.
Just some of my opinions, thoughts...